First Opinion By Ezekiel J. Emanuel Name the much-criticized federal program that has saved the U.S. $2.3 trillion. Hint: it starts with Affordable
First Opinion By Gretchen Jacobson Covid-19 is accelerating the Medicare trust fund’s dive toward insolvency
First Opinion By Sumit Agarwal Physicians who refuse to accept Medicaid patients breach their contract with society
First Opinion By Elsa Pearson and Austin Frakt Many seniors need hearing aids. Why doesn’t Medicare cover them?
First Opinion By Ateev Mehrotra I’m the perfect person to price shop for an operation. But the process went terribly
First Opinion By Robin Feldman Make list price the touchstone for drug pricing across the supply chain
Politics By Lev Facher Trump administration finalizes rule forcing insurers to disclose negotiated prices, including for drugs
First Opinion By Rebecca Kolins Givan President Trump is benefiting from single-payer, single-provider health care. We all should
First Opinion By Andrew Parece and Matthew Majewski Instead of eliminating drug rebates, use average sales price to set co-insurance levels
Special Report By Erin Brodwin and Casey Ross Two years of halting progress and high turnover preceded Atul Gawande’s exit as Haven CEO
Business By Casey Ross and Erin Brodwin Atul Gawande to depart as CEO of splashy health venture. Is it ‘a death knell’?
First Opinion By Eric Schneider Super Tuesday results suggest that Americans ‘aren’t looking for big structural changes’ in health care
Pharmalot By Ed Silverman Americans with employer coverage saw growth in drug spending outpace other medical costs
First Opinion By Dorothy Pomerantz I was fortunate to get post-23andMe genetic counseling. Everyone should have that option
First Opinion By Laura Hawks and Danny McCormick The ACA gave more Americans insurance, but not the health care they need
First Opinion By Christopher T. Robertson Does ‘no more copays, no more deductibles’ really represent radical health care reform?
First Opinion By Allyson Y. Schwartz Deadline looms to stop the Health Insurance Tax — but Congress has been there before
Off the Charts By Jennifer Adaeze Okwerekwu My baby needed expensive intensive care, but my insurer was taking a long weekend. How can this be?
First Opinion By Patrick J. Kennedy Mental health and addiction care are poorly covered by insurance networks
Pharmalot By Ed Silverman Biogen will offer discounts to a health plan if patients say its multiple sclerosis drugs don’t work
Politics By Lev Facher A new bill would let more doctors prescribe addiction treatments without waiting for insurers’ permission
First Opinion By Jeremy Schafer Should employers take a chance on little-known Embarc to pay for gene therapy?
First Opinion By David Boettiger The health system in my native Australia has a lot to learn from the U.S.
First Opinion By Shawn Morris Medicare’s Shared Savings Program results should have made headlines. It got a ‘collective shrug’ instead
First Opinion By Nav Persaud and Danielle Martin It’s time for Canada to embrace universal pharmacare and protect drug coverage from corporate erosion